Level of Tau Protein in Children Treated For Acute Lymphoblastic Leukemia
- 1 May 2006
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 34 (5) , 367-371
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Proteins released from degenerating neurons are surrogate markers for acute brain damageNeurobiology of Disease, 2004
- Impact of CNS Treatment on Mood in Adult Survivors of Childhood Leukemia: A Report From the Children’s Cancer GroupJournal of Clinical Oncology, 2003
- Long‐term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemiaCancer, 2002
- Tau and Axonopathy in Neurodegenerative DisordersNeuroMolecular Medicine, 2002
- Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy onlyThe Journal of Pediatrics, 2001
- Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemiaCancer, 2001
- Cognitive functions of adolescent childhood cancer survivors assessed by event‐related potentialsMedical and Pediatric Oncology, 2001
- Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignanciesLeukemia, 2000
- Tau Protein Function in Axonal FormationNeurochemical Research, 2000
- A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiationCancer, 1998